Related Experiment Videos
Antidepressants in chronic neuropathic pain
Consalvo Mattia1, Flaminia Coluzzi
1Department of Anesthesia, Intensive Care Medicine and Pain Therapy, University La Sapienza - Roma, Italy. consalvo.mattia@uniroma1.it
Mini Reviews in Medicinal Chemistry
|October 8, 2003
Summary
This review explores antidepressant drugs for pain relief, highlighting older tricyclic antidepressants (TCAs) as effective treatments. Newer antidepressants show promise but require more clinical trials for pain management.
Area of Science:
- Pharmacology
- Neurology
- Clinical Medicine
Background:
- Antidepressant drugs are increasingly recognized for their analgesic properties.
- Tricyclic antidepressants (TCAs) have established efficacy in pain management.
- Emerging research investigates newer antidepressant classes for pain relief.
Purpose of the Study:
- To review clinical studies on the analgesic effects of antidepressant drugs.
- To explore novel mechanisms underlying antidepressant-induced analgesia.
- To examine potential new routes of administration for these agents.
Main Methods:
- Comprehensive literature review of clinical trials and mechanistic studies.
- Analysis of data on both older TCAs and newer antidepressant classes.
- Evaluation of evidence for efficacy and safety in pain management.
Main Results:
- Older TCAs remain a benchmark for analgesic efficacy.
- Recent findings suggest potential analgesic benefits of newer antidepressants.
- Further research is needed to elucidate mechanisms and optimize use.
Conclusions:
- Antidepressant-assisted analgesia is a growing field with significant clinical implications.
- While TCAs are proven, newer agents warrant further investigation.
- Controlled trials are essential to validate the use of newer antidepressants for pain.